INS and type 2 diabetes mellitus: Pioglitazone (PIO) (Figure 6) improves the sensitivity of peripheral tissues to insulin, controls glycemia, dyslipidemia and hypertension, and also reduces albuminuria in patients with type 2 diabetes.